These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9920511)

  • 1. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
    Atherosclerosis; 1999 Jan; 142(1):105-12. PubMed ID: 9920511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.
    BMJ; 1991 Oct; 303(6807):893-6. PubMed ID: 1933004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
    Humphries SE; Cooper JA; Seed M; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil HAW;
    Atherosclerosis; 2018 Jul; 274():41-46. PubMed ID: 29751283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
    Neil HA; Hawkins MM; Durrington PN; Betteridge DJ; Capps NE; Humphries SE;
    Atherosclerosis; 2005 Apr; 179(2):293-7. PubMed ID: 15777544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
    Neil HA; Huxley RR; Hawkins MM; Durrington PN; Betteridge DJ; Humphries SE;
    Atherosclerosis; 2003 Sep; 170(1):73-8. PubMed ID: 12957684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register.
    Humphries SE; Cooper JA; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil AHW;
    Atherosclerosis; 2019 Feb; 281():207-212. PubMed ID: 30458964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.
    Neil A; Cooper J; Betteridge J; Capps N; McDowell I; Durrington P; Seed M; Humphries SE
    Eur Heart J; 2008 Nov; 29(21):2625-33. PubMed ID: 18840879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia.
    Sijbrands EJ; Westendorp RG; Paola Lombardi M; Havekes LM; Frants RR; Kastelein JJ; Smelt AH
    Atherosclerosis; 2000 Apr; 149(2):421-5. PubMed ID: 10729393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
    Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records.
    Iyen B; Qureshi N; Weng S; Roderick P; Kai J; Capps N; Durrington PN; McDowell IF; Soran H; Neil A; Humphries SE
    Atherosclerosis; 2020 Dec; 315():131-137. PubMed ID: 33187671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
    Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
    J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study.
    Sijbrands EJ; Westendorp RG; Defesche JC; de Meier PH; Smelt AH; Kastelein JJ
    BMJ; 2001 Apr; 322(7293):1019-23. PubMed ID: 11325764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and measurement of hypercholesterolaemia in South Africans attending general practitioners in private practice--the cholesterol monitor.
    Steyn K; Fourie JM; Shepherd J
    S Afr Med J; 1998 Dec; 88(12):1569-74. PubMed ID: 9930253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygote men with familial hypercholesterolaemia may have an abnormal triglyceride response post-prandially. Evidence for another predictor of vascular risk in familial hypercholesterolaemia.
    Kolovou GD; Anagnostopoulou KK; Pilatis ND; Iraklianou S; Hoursalas IS; Liberi S; Pavlidis AN; Dritsas A; Mikhailidis DP; Cokkinos DV
    Int J Clin Pract; 2005 Mar; 59(3):311-7. PubMed ID: 15857328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study.
    Huxley RR; Hawkins MH; Humphries SE; Karpe F; Neil HA;
    Stroke; 2003 Jan; 34(1):22-5. PubMed ID: 12511745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of coronary atherosclerosis in asymptomatic heterozygous patients with familial hypercholesterolemia.
    Miida T; Nakamura Y; Okada M
    J Cardiol; 1996 Aug; 28(2):71-7. PubMed ID: 8814524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
    Neil HA; Seagroatt V; Betteridge DJ; Cooper MP; Durrington PN; Miller JP; Seed M; Naoumova RP; Thompson GR; Huxley R; Humphries SE
    Heart; 2004 Dec; 90(12):1431-7. PubMed ID: 15547022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia.
    Kontula K; Vuorio A; Turtola H; Saikku P
    Lancet; 1999 Jul; 354(9172):46-7. PubMed ID: 10406370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.